IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

WESTBROOK, Maine -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst™ CLIPs, making complete kidney function evaluation part of the most common point-of-care chemistry profiles. Available beginning in June to customers in the United States and Canada, the integration expands access to advanced kidney assessment at scale, enabling veter…